Early research (Phase 1)Study completedNCT01491893What this trial is testingPVSRIPO for Recurrent Glioblastoma (GBM)Who this might be right forGBMGlioblastomaGlioma+1 more Istari Oncology, Inc. 61
Early research (Phase 1)Study completedNCT03615404What this trial is testingCytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent MedulloblastomaWho this might be right forGlioblastomaMalignant GliomaMedulloblastoma Recurrent+3 more Gary Archer Ph.D. 11
Early research (Phase 1)Active Not RecruitingNCT06410248What this trial is testingTriapine in Combination With Temozolomide for the Treatment of Patients With Recurrent GlioblastomaWho this might be right forRecurrent Glioblastoma, IDH-WildtypeRecurrent WHO Grade 2 GliomaRecurrent WHO Grade 3 Glioma+1 more Northwestern University 30
Testing effectiveness (Phase 2)Study completedNCT02986178What this trial is testingLerapolturev in Recurrent Malignant GliomaWho this might be right forMalignant Glioma Istari Oncology, Inc. 121
Testing effectiveness (Phase 2)Looking for participantsNCT06444412What this trial is testingAn Investigational Scan (Ga-68 PSMA-11 PET/CT) for Detection of Disease Recurrence or Progression in Patients With GliomaWho this might be right forWHO Grade 3 GliomaWHO Grade 4 Glioma Mayo Clinic 25
Early research (Phase 1)Not Yet RecruitingNCT07385846What this trial is testingPilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair DeficiencyWho this might be right forGlioblastomaMismatch Repair Deficiency Jennifer Leddon 8
Testing effectiveness (Phase 2)Looking for participantsNCT06160206What this trial is testingRetifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent GlioblastomaWho this might be right forRecurrent GlioblastomaRecurrent WHO Grade 4 Glioma Academic and Community Cancer Research United 134
Testing effectiveness (Phase 2)Ended earlyNCT04915404What this trial is testingBerubicin in Adult Patients With Recurrent Glioblastoma Multiforme (WHO Grade IV)Who this might be right forRecurrent Glioblastoma Multiforme WPD Pharmaceuticals Sp. z o.o. 5
Very early researchActive Not RecruitingNCT05182905What this trial is testingAZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma PatientsWho this might be right forGlioblastomaGliomaGlioblastoma Multiforme+1 more Nader Sanai 97
Early research (Phase 1)Looking for participantsNCT05460507What this trial is testingSafety & Efficacy/Tolerability of Rhenium-186 NanoLiposomes (186RNL) for Patients Who Received a Prior 186RNL TreatmentWho this might be right forGlioma Plus Therapeutics 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07386002What this trial is testingThe GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent GliomaWho this might be right forGlioblastoma IDH (Isocitrate Dehydrogenase) Wildtype T-MAXIMUM Pharmaceutical Inc 40
Testing effectiveness (Phase 2)Looking for participantsNCT05765812What this trial is testingDebio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed GlioblastomaWho this might be right forGlioblastoma IDH (Isocitrate Dehydrogenase) WildtypeAstrocytoma, Grade III Debiopharm International SA 116
Testing effectiveness (Phase 2)Study completedNCT02343406What this trial is testingAdult Study: ABT-414 Alone or ABT-414 Plus Temozolomide vs. Lomustine or Temozolomide for Recurrent Glioblastoma Pediatric Study: Evaluation of ABT-414 in Children With High Grade GliomasWho this might be right forGlioblastoma AbbVie 266
Testing effectiveness (Phase 2)Study completedNCT01738646What this trial is testingPh II SAHA and Bevacizumab for Recurrent Malignant Glioma PatientsWho this might be right forRecurrent Glioblastoma MultiformeMalignant GliomaAdult Brain Tumor Duke University 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT01903330What this trial is testingERC1671/GM-CSF/Cyclophosphamide for the Treatment of Glioblastoma MultiformeWho this might be right forGlioblastomaGliosarcoma Epitopoietic Research Corporation 84
Early research (Phase 1)Looking for participantsNCT06253234What this trial is testingSafety and Efficacy Study for DC Vaccine in Recurrent or Progressive High-grade GliomasWho this might be right forWHO Grade III GliomasWHO Grade IV Gliomas Beijing Tiantan Hospital 12
Early research (Phase 1)Study completedNCT01240460What this trial is testingExploratory Study of XL765 (SAR245409) or XL147 (SAR245408) in Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical ResectionWho this might be right forGlioblastomaAstrocytoma, Grade IV Sanofi 40
Early research (Phase 1)Not Yet RecruitingNCT07422363What this trial is testingTesting the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent GlioblastomaWho this might be right forRecurrent Glioblastoma, IDH-WildtypeRecurrent GliosarcomaRecurrent WHO Grade 4 Glioma National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT03291314What this trial is testingClinical Trial on the Combination of Avelumab and Axitinib for the Treatment of Patients With Recurrent GlioblastomaWho this might be right forRecurrent Glioblastoma (WHO-Grade IV Glioma) Universitair Ziekenhuis Brussel 52
Testing effectiveness (Phase 2)WithdrawnNCT03973879What this trial is testingCombination of PVSRIPO and Atezolizumab for Adults With Recurrent Malignant GliomaWho this might be right forMalignant Glioma Darell Bigner